BioSig Technologies (BSGM) Corporate Presentation from NobleCon18Research, News and Market Data on BioSig TechnologiesNobleCon 18 Complete Rebroadcast
|
Access to Exclusive Content. FREE for Registered Users Only.
Join the Channelchek Investor Community to access equity research, video content, events, and much more. All at no cost.
‌


Welcome to the Channelchek Investor Community
We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.
Don't have an account? Join
Forgot passwordBy clicking “Log In” you agree to Channelchek.com Terms of Use and acknowledge that Channelchek.com Privacy Policy applies to you.
Related News
‌


4/22/2026
Industrials
Titan International (TWI) – Model Tweaks Ahead of 1Q26 Earnings
Model Tweaks. With 1Q26 results to be released next week, we reviewed our assumptions and resulting estimates for the quarter. Titan continues to face inflation and tariff pressure and, more recently, extra...
2 min read
‌


4/22/2026
Health
Greenwich LifeSciences, Inc. (GLSI) – Preliminary FLAMINGO-01 Data Presented At AACR
Phase 3 FLAMINGO-01 Data Presented. Greenwich LifeSciences and the FLAMINGO-01 Steering Committee made two presentations at the American Association of Cancer Research (AACR) 2026 Meeting. One detailed the FLAMINGO-01 trial design...
2 min read
‌


4/21/2026
Media and Entertainment
Release – Travelzoo Q1 2026 Earnings Conference Call on April 23 at 11:00 AM ET
Travelzoo, the club for travel enthusiasts, will host a conference call to discuss the Company’s financial results for the first quarter ended March 31, 2026. Travelzoo will issue a press...
2 min read
‌


4/21/2026
Health
Release – Cardiff Oncology to Present Updated Phase 2 Data of Onvansertib in First-Line RAS-Mutated mCRC in a Rapid Oral Session at ASCO 2026
Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel cancer therapies, today announced it will present updated data from CRDF-004, a randomized dose-finding Phase...
4 min read
Inbox Intel from Channelchek.
Informed investors make more money. And it’s all about timing. Get it when it happens.